Literature DB >> 16122419

Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha.

Christoph Handschin1, Jiandie Lin, James Rhee, Anne-Kathrin Peyer, Sherry Chin, Pei-Hsuan Wu, Urs A Meyer, Bruce M Spiegelman.   

Abstract

Inducible hepatic porphyrias are inherited genetic disorders of enzymes of heme biosynthesis. The main clinical manifestations are acute attacks of neuropsychiatric symptoms frequently precipitated by drugs, hormones, or fasting, associated with increased urinary excretion of delta-aminolevulinic acid (ALA). Acute attacks are treated by heme infusion and glucose administration, but the mechanisms underlying the precipitating effects of fasting and the beneficial effects of glucose are unknown. We show that the rate-limiting enzyme in hepatic heme biosynthesis, 5-aminolevulinate synthase (ALAS-1), is regulated by the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha). Elevation of PGC-1alpha in mice via adenoviral vectors increases the levels of heme precursors in vivo as observed in acute attacks. The induction of ALAS-1 by fasting is lost in liver-specific PGC-1alpha knockout animals, as is the ability of porphyrogenic drugs to dysregulate heme biosynthesis. These data show that PGC-1alpha links nutritional status to heme biosynthesis and acute hepatic porphyria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122419     DOI: 10.1016/j.cell.2005.06.040

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  132 in total

Review 1.  Regulation of metabolism: the circadian clock dictates the time.

Authors:  Saurabh Sahar; Paolo Sassone-Corsi
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

2.  Circadian metabolic regulation through crosstalk between casein kinase 1δ and transcriptional coactivator PGC-1α.

Authors:  Siming Li; Xiao-Wei Chen; Lei Yu; Alan R Saltiel; Jiandie D Lin
Journal:  Mol Endocrinol       Date:  2011-11-03

3.  Acute intermittent porphyria: fatal complications of treatment.

Authors:  P E Stein; M N Badminton; J H Barth; D C Rees; R Sarkany; M F Stewart; T M Cox
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

Review 4.  Endogenous ligands for nuclear receptors: digging deeper.

Authors:  Michael Schupp; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

Review 5.  Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.

Authors:  Dulmini P Barupala; Stephen P Dzul; Pamela Jo Riggs-Gelasco; Timothy L Stemmler
Journal:  Arch Biochem Biophys       Date:  2016-01-16       Impact factor: 4.013

6.  Link between porphyria and fasting uncovered.

Authors:  David Secko
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

7.  Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo.

Authors:  Thomas A Pedersen; Oxana Bereshchenko; Susana Garcia-Silva; Olga Ermakova; Elke Kurz; Susanne Mandrup; Bo T Porse; Claus Nerlov
Journal:  EMBO J       Date:  2007-02-08       Impact factor: 11.598

8.  Mitochondria Biogenesis Modulates Iron-Sulfur Cluster Synthesis to Increase Cellular Iron Uptake.

Authors:  Ping La; Joseph H Oved; Valentina Ghiaccio; Stefano Rivella
Journal:  DNA Cell Biol       Date:  2020-04-13       Impact factor: 3.311

9.  PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis.

Authors:  Jennifer L Estall; Jorge L Ruas; Cheol Soo Choi; Dina Laznik; Michael Badman; Eleftheria Maratos-Flier; Gerald I Shulman; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

10.  Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1alpha.

Authors:  M M Schilling; J K Oeser; J K Chandy; B P Flemming; S R Allen; R M O'Brien
Journal:  Diabetologia       Date:  2008-06-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.